The Metabolic Effect of Walnut Consumption in Healthy Men and Healthy Postmenopausal Women
1 other identifier
interventional
60
1 country
1
Brief Summary
The objectives of the proposed study are to assess the effect of walnut consumption on parameters of lipid metabolism, glucose metabolism, incretins and adipokines, endothelial function and blood pressure in healthy men and healthy postmenopausal women
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Aug 2010
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 25, 2010
CompletedFirst Posted
Study publicly available on registry
August 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedJanuary 8, 2013
January 1, 2013
1.7 years
August 25, 2010
January 7, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Fasting non-HDL-cholesterol
8 weeks
Secondary Outcomes (12)
area under the triglyceride curve (AUC-TG)
8 weeks
incremental area under the triglyceride curve (iAUC-TG)
8 weeks
LDL-cholesterol
8 weeks
HDL-cholesterol
8 weeks
triglyceride
8 weeks
- +7 more secondary outcomes
Study Arms (2)
walnut
EXPERIMENTALwestern type diet with 48 g walnut per day
control
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Postmenopausal healthy women and healthy men
- Age \> 50 yrs
You may not qualify if:
- Evidence of alcohol, tabacco or drug abuse
- Obesity ≥ 35 kg/m2
- Diabetes mellitus
- Hypertension
- LDL-cholesterol \> 190 mg/dl, Triglycerides \> 350 mg/dl
- History of atherosclerotic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Med Dept. 2 Grosshadern
Munich, 81377, Germany
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
August 25, 2010
First Posted
August 26, 2010
Study Start
August 1, 2010
Primary Completion
April 1, 2012
Study Completion
August 1, 2012
Last Updated
January 8, 2013
Record last verified: 2013-01